Considerations in payer coverage of digital therapeutics – Healthcare Economist
[ad_1] The Digital Therapeutics Alliance defines a digital therapeutic (DTx) as “evidence-based therapeutic interventions that are driven by high-quality software […]
[ad_1] The Digital Therapeutics Alliance defines a digital therapeutic (DTx) as “evidence-based therapeutic interventions that are driven by high-quality software […]
[ad_1] By Jeff Goldsmith Years ago, the largest living thing in the world was thought to be the blue whale. Then someone discovered that the […]
[ad_1] By STEVEN ZECOLA This study tracks the decades-long journey to harness alpha-synuclein as a treatment for Parkinson’s disease. Steven Zecola an activist who tracks […]
[ad_1] One reason is that reimbursement rates for Medicaid are lower than for Medicare or commercial insurance. Another (often overlooked) […]
[ad_1] Nobel prize winner Daniel Kahneman passed away today. His work incorporating psychology into economics through Prospect Theory has been a major advance. From the […]
[ad_1] By KIM BELLARD These are not happy times in America. Now, I’m not thinking about the increasing cultural wars, the endless political bickering, the […]
[ad_1] How did health care prices change over the past 2 decades. That is the question a paper by Papanicolas (2024) aims to answer, comparing […]
[ad_1] Many researchers are interested in how cost sharing impacts health care utilization, cost and patient outcomes. This is especially […]
[ad_1] Modelling health care cost is often problematic because are distributed in a non-normal manner. Typically, there are a large […]
[ad_1] By RANDY SOUDERS During the years I served as Chairman of the Board for Jean Kennedy Smith’s Arts and Disability program, Very Special Arts […]